Search Within
Document Type
200-658-0
Applied Filters:
Keyword:'200-658-0'
Showing 1-28 of 28 results for "200-658-0" within Technical Documents
MILLIPLEX MAP Phospho ATF2 (Thr69/71) MAPmates
fluorescent analytical test instrumentation marketed under the
name of Luminex100, 200, HTS.
Page 2 of 7 Millipore 46-658 Rev. 26-JUL-2010
MATERIALS REQUIRED BUT NOT PROVIDED
Reagents
Product Information Sheet - MAK354
and standard curve wells at ex = 658 nm/em = 708 nm
in endpoint mode.
Results
1. For the Homocysteine Standard Curve, subtract the
zero standard (0 pmol/well) reading from the
remaining
Data Sheet - E6779
1. Wilson, I.A. et al., Cell, 37(3), 767-778 (1984).
2. Narayanan, S.R., J. Chromatogr. A, 658(2),
237-258 (1994).
3. Uhlen, M., and Moks, T., Methods Enzymol., 185,
129-143 (1990).
Protocol: Human PYY (Total) ELISA Kit - 96-Well Plate
82% 232 102%
500 525 82% 658 106%
C
0 (Basal) 144 -- 172 --
40 172 70% 214 105%
100 215 71% 266 94%
Process Guidance Cellvento™ CHO-210 Medium
final pH of 5.2 – 5.8.
4. Measure the osmolality of the solution. Final osmolality
should be 658 +/– 30 mOsmol/kg. Sterilize by membrane
filtration using a 0.22 µm Millipore Express® PLUS or
Durapore
Process Guidance - Cellvento CHO 210
Confirm final pH of 5.2 – 5.8.
• Measure the osmolality of the solution. Final osmolality should be 658 +/– 30 mOsmol/kg.
Sterilize by membrane filtration using a 0.22 μm Millipore Express® PLUS or Durapore
Advance your Epigenetics Research
Number 03-110)
600
500
400
Fo
ld
E
nr
ic
hm
en
t
300
200
100
IgG
1
Ago2
506
0
http://www.emdmillipore.com/techservice
http://www.emdmillipore.com?cid
Human C-Peptide
tr
if
u
g
e
a
t
4
C
fo
r
2
0
m
in
.,
D
e
c
a
n
t,
a
n
d
C
o
u
n
t
1,2 - - 100
Magna ChIP™ HT96 (Cat. No. 17-10077)
ChIPAb+ CTCF
17-614 ChIPAb+ Trimethyl-Histone H3 (Lys4) 17-681 ChIPAb+ Dimethyl-Histone H3 (Lys9)
17-658 ChIPAb+ Acetyl-Histone H3 (Lys9) 17-630 ChIPAb+ Acetyl Histone H4
17-625 ChIPAb+ Trimethyl-Histone
Magna ChIP™ HT96
ChIPAb+ CTCF
17-614 ChIPAb+ Trimethyl-Histone H3 (Lys4) 17-681 ChIPAb+ Dimethyl-Histone H3 (Lys9)
17-658 ChIPAb+ Acetyl-Histone H3 (Lys9) 17-630 ChIPAb+ Acetyl Histone H4
17-625 ChIPAb+ Trimethyl-Histone
EZ-Magna ChIP™ HT96 (Cat. No. 17-10078)
ChIPAb+ CTCF
17-614 ChIPAb+ Trimethyl-Histone H3 (Lys4) 17-681 ChIPAb+ Dimethyl-Histone H3 (Lys9)
17-658 ChIPAb+ Acetyl-Histone H3 (Lys9) 17-630 ChIPAb+ Acetyl Histone H4
17-625 ChIPAb+ Trimethyl-Histone
Magna ChIP¿ A/G
ChIPAb+ CTCF
17-614 ChIPAb+ Trimethyl-Histone H3 (Lys4) 17-681 ChIPAb+ Dimethyl-Histone H3 (Lys9)
17-658 ChIPAb+ Acetyl-Histone H3 (Lys9) 17-630 ChIPAb+ Acetyl Histone H4
17-625 ChIPAb+ Trimethyl-Histone
EZ-Magna ChIP¿ A/G
ChIPAb+ CTCF
17-614 ChIPAb+ Trimethyl-Histone H3 (Lys4) 17-681 ChIPAb+ Dimethyl-Histone H3 (Lys9)
17-658 ChIPAb+ Acetyl-Histone H3 (Lys9) 17-630 ChIPAb+ Acetyl Histone H4
17-625 ChIPAb+ Trimethyl-Histone
Magna ChIP A/G One-Day Chromatin Immunoprecipitation Kits
ChIPAb+ CTCF
17-614 ChIPAb+ Trimethyl-Histone H3 (Lys4) 17-681 ChIPAb+ Dimethyl-Histone H3 (Lys9)
17-658 ChIPAb+ Acetyl-Histone H3 (Lys9) 17-630 ChIPAb+ Acetyl Histone H4
17-625 ChIPAb+ Trimethyl-Histone
Shaping Epigenetics Discovery - Epigenetics Product Selection Brochure
CHROMATIN IMMUNOPRECIPITATION: KITS
Tissue ChIP
BA
0
100F
ol
d
En
ric
hm
en
t
Cortex Heart
Tissue
Kidney
200
300
400
50
150
250
350 GAPDH
Upstr(-)
Detergents Booklet
0�
0�
��
�.
�
�-
�0
�-
��
��
�0
CH
AP
SO
��
0�
0�
��
0.
�
�
��
�0
00
DD
M
AB
��
�0
00
��
�.
�
�.
�
DD
M
ISODIS 2998 (1)
=×=
×
= − g
CFUN 644 100,3102961022,2
658
Example 2
Table 2 — Example 2
Dilution Plate 1 Plate 2
D5 311 286
D6 27 21
Apoptosis - Antibodies, Reagents and Kits
Anti-PI3 Kinase, p101 H R WB Rb IgG1 200 µg 07-281 $309
Anti-PI3 Kinase, p110α H WR IP Rb IgG 200 µg 07-658 $309
Anti-PI3 Kinase, p110β H M R B IP Rb IgG 200 µg
Cytoskeletal Signaling Antibodies, Reagents and Kits
Pur Rb IgG 200 µg 06-568
Anti-PI3 Kinase, p101 H R WB Pur Rb IgG1 200 µg 07-281
Anti-PI3 Kinase, p110α H WR IP Pur Rb IgG 200 µg 07-658
Anti-PI4-Kinase β H M R IP WB
MAPK: Antibodies, Proteins, Kits, siRNA and Reagents
Pur Rb IgG 200 µg 06-568
Anti-PI3 Kinase, p101 H R WB Pur Rb IgG1 200 µg 07-281
Anti-PI3 Kinase, p110a H WR IP Pur Rb IgG 200 µg 07-658
Anti-PI4-Kinase b H M R IP WB
Organic and Molecular Electronics
Type IIIx3) nFcm-2 at 102 Hz
(Figure 3) vs. ~11 nFcm-2 for 300 nm-thick SiO2.
102 103 104 105
0
200
400
600
800
Ca
pa
ci
ta
nc
e
(n
F/
cm
2
Stem Cell and Specialty Cell Culture Product Guide
Solution 100 mL SCR006
600 100
50
0
500
N
o.
o
f
ce
lls
(t
ho
us
an
ds
)
%
V
iability
400
300
200
XP725 Antibody List 013M4793
Phosphatase 2 A/A P8109 5515, 24672, 19052 Ppp2ca,PPP2CA NP_002706.1,NP_058735.1,NP_062284.1 P y y y
658 Serine/Threonine Protein Phosphatase 1β P7484 5500, 25594, 19046 PPP1CB,Ppp1cb NP_996759.1,NP_037197.1
Aldrichimica Acta Volume 50 Number 2
Bioconjugation—A Versatile and Essential Research Tool
Greg T. Hermanson
ChemBioChem 2009, 10, 658.
(21) Liu, Y.; Feizi, T.; Campanero-Rhodes, M. A.; Childs, R. A.; Zhang, Y.;
Mulloy, B.; Evans
XP725 Antibody List
Phosphatase 2 A/A P8109 5515, 24672, 19052 Ppp2ca,PPP2CA NP_002706.1,NP_058735.1,NP_062284.1 P y y y
658 Serine/Threonine Protein Phosphatase 1β P7484 5500, 25594, 19046 PPP1CB,Ppp1cb NP_996759.1,NP_037197.1
3D BIOPRINTING: Printing a Brighter Future
Concaro, S.; Brittberg, M.;
Lindahl, A.; Gatenholm, P.; Enejder, A.; Simonsson, S. Sci. Rep. 2017, 7,
658.
(7) Kuo, C.-Y.; Eranki, A.; Placone, J. K.; Rhodes, K. R.; Aranda-Espinoza,
H.; Fernandes, R.;
3D BIOPRINTING: Printing a Brighter Future
Concaro, S.; Brittberg, M.;
Lindahl, A.; Gatenholm, P.; Enejder, A.; Simonsson, S. Sci. Rep. 2017, 7,
658.
(7) Kuo, C.-Y.; Eranki, A.; Placone, J. K.; Rhodes, K. R.; Aranda-Espinoza,
H.; Fernandes, R.;
Inhibitor Sourcebook 3rd Edition
1 mg
Protein Kinase C Inhibitor, EGF-R
Fragment 651-658, Myristoylated
476475 [Myr-N-RkRTLRRL-Oh; Myristoylated eGF-R Fragment (651-658), PkC Inhibitor]
Epidermal growth-factor receptor (EGF-R)